CRMD logo

CorMedix Inc.

CRMD
Healthcare|Biotechnology|US
$5.32
+0.09 (+1.72%)
Tangible Book / Share
$0.92
Graham Number
$17.76
Cash / Share
$3.27
Next Earnings Report
Nov 12, 2026
EPS est. -$0.09 · Revenue est. $52.8M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (2)

Jan 2028
Est. completion
P3Central Line Associated Blood Stream Infections (CLABSI)
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
NCT06822426n=200
Jul 2028
Est. completion
P4Catheter-Related Infections
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
NCT06714864n=36

Recent Press Releases

CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
Nov 6, 2026 · GlobeNewsWire
CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position
Nov 2, 2026 · GlobeNewsWire
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
Oct 19, 2026 · GlobeNewsWire
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Oct 15, 2026 · PRNewsWire
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
Sep 1, 2026 · GlobeNewsWire
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 13, 2026 · GlobeNewsWire

SEC Filings (65)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 19, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 7, 20268-KMaterial eventDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jul 1, 20268-KMaterial eventDocumentIndex
Jun 25, 2026S-8 POSEmployee stock planDocumentIndex
Jun 24, 20268-KMaterial eventDocumentIndex
Jun 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 8, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 27, 20268-KMaterial eventDocumentIndex
Apr 17, 2026PRE 14AProxy / shareholder voteDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 6, 20268-KMaterial eventDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Jan 2, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 1, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 13, 2025S-8Employee stock planDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Oct 24, 2025DEF 14AProxy / shareholder voteDocumentIndex
Oct 14, 2025PRER14ADocumentIndex
Oct 7, 2025S-3ASRShelf registrationDocumentIndex
Oct 7, 2025RWDocumentIndex
Oct 6, 2025S-3ASRShelf registrationDocumentIndex
Oct 6, 2025RWDocumentIndex
Sep 30, 2025S-3Shelf registrationDocumentIndex
Sep 30, 20258-K/AMaterial eventDocumentIndex
Sep 15, 2025PRE 14AProxy / shareholder voteDocumentIndex
Sep 12, 2025SC 13DActivist / 5%+ stakeDocumentIndex